Proteins of the extracellular matrix often have multiple functions to facilitate complex tasks ranging from signaling to structural support. Here we have focused on the function of one of the matrix proteins expressed in bones and teeth, the matrix adhesion protein ameloblastin (AMBN). Transgenic mice with 5-fold elevated AMBN levels in mandibles suffered from root cementum resorption, delamination, and reduced alveolar bone thickness. AMBN gain of function also resulted in a significant reduction in trabecular bone volume and bone mass dentistry in 42 days postnatal mouse jaws. In an in vitro model of osteoclastogenesis, AMBN modulated osteoclast differentiation from bone marrow derived monocytes (BMMCs), and dramatically increased osteoclast numbers and resorption pits. Furthermore, AMBN more than doubled BMMC adhesion, accelerated cell spreading, and promoted podosome belt and actin ring formation. These effects were associated with elevated ERK1/2 and AKT phosphorylation as well as higher expression of osteoclast activation related genes. Blocking integrin α2β1 and ERK 1/2 pathways alleviated the effects of AMBN on osteoclast differentiation.
INTRODUCTION
Adhesion of cells to extracellular matrices is of fundamental importance for a wide range of cellular functions, including cell differentiation, proliferation, and survival [1] . Among many cell types in which surface adhesion plays a critical role, osteoclasts are arguably some of the most prominent, likely because of the necessity of osteoclast precursors, i.e. circulatory hematopoitic monocytes/macrophages, to attach to specific resorption sites and further differentiate, and because of the proximity of osteoclasts to bone as a requirement for leakage-free delivery of acids and proteases to enable targeted bone resorption [2] . Osteoclast surface attachment is a first and essential step in a cascade of events that continues with osteoclast polarization, formation of podosomes and a sealing zone, and finally secretion of acids and proteases for the resorption of bone.
The contact of osteoclasts with the apatitic bone surface activates small GTPases of the Rho family [3, 4] , which in turn induce osteoclast spreading, podosome formation and the formation of the sealing zone [5] [6] [7] . Adhesion of osteoclasts to matrices is aided by integrin receptors (αvβ3, αvβ5, α2β1, and αvβ1) [8] , linking osteoclast adhesion with cytoskeletal polarization and activation for bone resorption [9] .
From a clinical perspective, changes in osteoclast number or activity have dramatic effects on the life of an organism: Osteoclast hyperactivity results in osteoporosis, while osteoclast defects cause increased bone density in individuals suffering from osteopetrosis. Changes in osteoclast physiology not only affect the entire skeletal system but also the jaws and teeth, where inflammatory or pro-inflammatory cytokines cause root resorption as a result of orthodontic treatment [10, 11] or bone resorption and associated tooth loss as a result of periodontal disease [12, 13] . The intricate balance between bone resorption and apposition is exemplified during physiological tooth movement where bone resorption at movement-direction alveolar bone walls and bone apposition on the contralateral side plays a role in the continuous maintenance of the attachment apparatus.
The matrix adhesion protein AMBN [14] is one of several extracellular matrix proteins that are significantly upregulated during physiological tooth movement [un- published data], [15, 16] . While first discovered in ameloblasts [17] , AMBN is also expressed by osteoblasts [18] , cementoblasts [19] and Epithelial Rests of Malassez (ERM) in the periodontal ligament [15] . The AMBN protein sequence features a fibronectin interaction site [20] and heparin binding domains [21, 22] . In addition, there is a potential α2β1 integrin binding domain and a thrombospondin cell adhesion motif located in rodent ameloblastin proteins [23] . Mutation of AMBN results in detachment of ameloblasts from the developing enamel matrix and a loss of cell polarity in an AMBN null mouse model [14] . The effect of AMBN on cell adhesion has been shown to involve RhoA and cell cycle progression through p27 [24] .
To determine the function of AMBN in mineralized tissue homeostasis, we generated an Ambn overexpressing transgenic mouse model and investigated the effect of AMBN on osteoclastogenesis. Based on the importance of surface adhesion on osteoclastogenesis we conducted a series of in vivo and in vitro studies to test whether and how increased AMBN levels would affect osteoclast activity and bone resorption.
Our studies shed new light on molecular factors contributing to osteoclastogenesis and explain how the ECM adhesion protein AMBN affects the mineralized state of periodontal tissues.
MATERIALS AND METHODS

Transgene constructs and transgenic mice
The human keratin 14 (K14) promoter was chosen to drive the Ambn transgene because K14 was expressed in HERS, ERM and bone [25] , and the K14 promoter has resulted in substantial overexpression yields in our laboratory [26] . For our studies, two transgenic constructs were generated using a modified pSKII-trans vector in which the K14 promoter, the polyA signal (a generous gift from Dr. Elaine Fuchs, Rockefeller University), the β-Globulin intron, the mouse Ambn coding region, or the LacZ gene were inserted. The β-Globulin intron was used to ensure that the transgenes were properly transcribed. The transgenic fragments were freed from pSKII-K14-Ambn or pSKII-K14-LacZ by digesting the constructs with Sac I and Hind III, gel purified, and microinjected into mouse zygotes [27] . The human K14 promoter-driven Ambn transgenic mice and K14 promoter-driven LacZ transgenic mice were handled in accordance with the UIC Use of Animals in Research Policy.
Genotyping
Genotyping was carried out using tails collected from Ambn or LacZ transgenic heterozygous litters. The tails were lysed in DirectPCR (Tail) buffer (Qiagen, Los Angeles, CA) and PCR amplification was performed using K14 promoter specific primers: 5'GCTTAGCCAGGGTGACAGAG 3' (forward) and 5'CACAGAGGCGTAAATGCAGA3' (reverse) [27] .
Whole mount X-gal staining and alizarin red staining
For whole mount X-gal staining, mandibles from LacZ transgenic mice at postnatal day 35 were fixed with 4% paraformaldehyde in PBS at 4C overnight. The samples were then incubated in the dark with a staining buffer containing 0.05 mM K 3 Fe(CN) 6 , 0.05 mM K 4 Fe(CN) 6 , 1 mM MgCl 2 , and 1 mg/ml X-gal at 37C for 7 hours.
For whole mount alizarin red staining, mandibles from wild type (WT) and Ambn transgenic mice at postnatal day 35 were fixed, dehydrated and then stained with saturated alizarin red S (Sigma, St Louis, MO) in 0.5% potassium hydroxide (KOH).
Micro-CT analysis
To visualize mineralized tissues, mandibular tissue blocks were analyzed using microcomputed tomography (micro-CT). For this purpose, 3D X-ray CT images were acquired using a high resolution scanner (Viva CT 40 Scanco Medical AG, Brüttisellen, Switzerland). The micro-CT images were segmented to obtain accurate 3D image data sets.
Scanning electron microscopy
Molars from mandibles of 35-day-old wild-type (WT) and Ambn transgenic (TG) mice were extracted and dehydrated in a series of ethanol, air dried and coated with goldpalladium. Scanning electron micrographs were taken using a JEOL Field Emission SEM (JSM-6320F).
Tissue processing
Mandibles from WT, Ambn or LacZ transgenic mice were dissected and fixed with 10% formalin at 4C. For un-decalcified ground sections, tissues were dehydrated, embedded in Technovit 7200 (Exakt Inc, Oklahoma, OK) and prepared into 10 micron sections for subsequent von Kossa staining. For decalcified paraffin sections, mandibles were de-mineralized in EDTA, and processed for paraffin sections. Sections were subjected to H & E staining, Villanueva staining, TRAP staining, in situ hybridization or immunohistochemistry.
In situ hybridization
In situ hybridization analysis was performed using a Digoxingenin (DIG)-labeled 
Von Kossa staining
Ground sections were stained with 5% silver nitrate for 1 hour under UV exposure and then de-stained with 5% sodium thiosulfate.
TRAP staining
Osteoclasts were visualized using a tartrate resistant acid phosphatase (TRAP) staining procedure. For this procedure, either fixed cells or de-paraffinized sections were incubated in acetate buffered solution containing naphthol AS-MX phosphate, Fast Garnet GBC salt, and tartrate solution (0.67 mol/l)(Sigma, St. Louis/MO) for 60 min, and then counterstained with hematoxylin.
AMBN protein expression and purification
The mouse Ambn coding region was amplified by PCR with a 5' Nde1 site and a 3' BamH1 site. The PCR products were inserted in the pET-28 expression vector and MER/ERK pathways.
Cell attachment
Adhesion assays were performed using 35 mm untreated culture dishes (Corning, NY). The dishes were coated with recombinant mouse AMBN (rmAMBN), BSA, or recombinant mouse amelogenin (rmAMEL) proteins at concentrations of 5 or 10 µg/ml at 4 0 C overnight, and blocked with 2% denatured BSA at room temperature for 1 hour.
After washing, 10 6 of BMMCs were seeded into each dish and incubated at 37 0 C for 4
hours. Nonadherent cells were removed by washing with PBS and the remaining cells were counted under a microscope.
F-actin staining
BMMCs were placed in rmAMBN coated 35 mm dishes. To elucidate podosome formation, cells were cultured for 12 hours. To induce actin ring formation, cells were cultured for 5 days in the presence of M-CSF (10 mg/ml) and RANKL (50 mg/ml). The cultured cells were fixed with 3.7 % formalin, permeabilized with 0.1 % Triton-100, and then stained with rhodamine -or FITC-conjugated phalloidin (Sigma). Flourescent images were captured under a Leica DMRX fluorescent microscope.
Bone resorption assay
BioCoat Osteologic MultiTest Slides (BD Biosciences, San Jose, CA) were coated with rmAMBN (10 µg/ml). 2x10 3 of BMMCs were seeded into each well and cultured for 5 days with M-CSF (10 ng/ml) and RANKL (50 ng/ml). The cells were removed with 6% NaOCl and each slice was washed with distilled water, air dried and examined for resorption pits. 
Protein extraction and western blot analysis
Statistical analysis
Quantitative data were presented as means ± SD from three independent experiments and compared with one way ANOVA statistical analysis tests. The difference between groups was considered statistically significant at P<0.05.
RESULTS
AMBN is expressed in Hertwig's Epithelial Root Sheet (HERS) and in the periodontal ligament of mouse molar teeth
Our interest in AMBN in the periodontium was peaked by a dramatic increase in AMBN expression in the Epithelial Rests of Malassaz (ERM) during tooth movement or after mechanical injury of cementum [15] , [16] . As a first step to understand AMBN function in the periodontal ligament, the temporo-spatial expression pattern of AMBN was mapped during tooth development. Using in situ hybridization analysis, AMBN mRNA was prominently localized in ameloblasts and HERS ( Fig. 1A ) as well as ERM (Fig. 1D ). ERM were identified as islands of cuboidal cells aligned parallel to the root surface in the midst of elongated periodontal ligament fibroblasts. Lower levels of mRNA were also detected in odontoblasts and dental pulp on postnatal day 12 ( Fig. 1 ).
AMBN mRNA were substantially enhanced in Ambn transgenic (TG) mice (Fig. 1B) . No signal was detected in the control, in which AMBN sense RNA was used as a probe (Fig.   1C ).
As a second step in our analysis of AMBN expression and function in periodontal tissues AMBN overexpressing transgenic mice driven by the human K14 promoter [27] were generated. To verify overexpression of the K14-driven transgene in HERS and ERM, a K14-LacZ transgenic mouse model was also created. Whole mount X-gal staining demonstrated the localization of the transgene in HERS and ERM cells (Fig. 1E ). [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Western blot analysis revealed two bands corresponding to the AMBN protein, one with a higher molecular weight at 55 kDa and a second with a lower molecular weight at 50 kDa (Fig. 1H ). The expression of AMBN gradually decreased from 6dpn to 20dpn in WT and TG mice (Fig. 1H) . Furthermore, densitometry analysis on western blots revealed that on postnatal day 10, AMBN was five times higher expressed in AMBN overexpressing mice than in WT controls.
Immunofluorescence-based comparison of AMBN and K14 localization in 10
days postnatal developing tooth roots demonstrated co-localization of both proteins in HERS cells ( Fig. 2A-D ). There were strings of small patches of overlapping AMBN/K14
labeling along the HERS cell membrane (Fig. 2D ). Cultured alveolar bone osteoblasts stained for both AMBN and K14 ( Fig. 2E-H ). There was an intense intracellular AMBN labeling in the periphery of the nuclear envelope (Fig. 2E ).
Ambn overexpression induces alveolar bone loss and tooth root resorption
Enamel of Ambn transgenic mice featured a dull surface and yellowish color ( Fig.   3B ), indicating that our Ambn overexpression model was associated with an enamel defect. Whole mount alizarin red staining revealed that the Ambn overexpressor suffered from significant bone loss at the crest of the alveolar bone as well as an increase in the periodontal ligament thickness (Fig. 3B ). Alveolar bone loss was most prominent at the crest of the first root of the first molar (Fig. 3B) . Micro-CT analysis revealed a reduction in alveolar bone wall thickness when comparing TG to WT counterparts ( Fig. 3D versus (Fig. 3I) . The approximately 10% reduction in trabecular bone volume and bone mass dentistry as a result of AMBN gain of function was a sizable and significant (p<0.05) effect. In contrast, bone surface/volume ratio (BS/BV) increased slightly and significantly (p<0.05) in AMBN overexpressors, while trabecular separation increased as well, but the difference was not significant (Fig. 3I ).
Ambn overexpression is associated with increased osteoclast/cementoclast activity
Villanueva's Osteochrome staining of ultrathin ground sections demonstrated an acellular cementum layer featuring a homogeneous structural integration with the underlying root dentin in controls (Fig. 4A) . A number of layers displayed metachromatic colorations, and transitions occurred gradually between each layer (Fig.   4A ). In Ambn over-expressing transgenic mice, the junction between acellular cementum and dentin was disrupted (Figs. 4B) .
There was an open channel between periodontal ligament and dental pulp with a group of periodontal fibroblasts crossing in between (Fig.   4B ). Von Kossa staining of WT mouse molars at PN 35 revealed a dark brown and intact acellular cementum surface (Fig. 4C) , while acellular cementum was de-laminated from the root surface in Ambn over-expressing mice (Fig. 4D) . In addition, a few giant cells were attached on the surface of the acellular cementum (Fig. 4D ). In tandem with increased root resorption, TRAP staining of molar root sections indicated higher osteoclast activity in the periodontal ligament of Ambn overexpressors (Fig. 4F ) than in that of WT mice ( 
AMBN enhances BMMS adhesion and induces adhesion-dependent phosphorylation of ERK and AKT
Previous studies have highlighted the role of AMBN as an extracellular adhesion molecule [14] . We therefore hypothesized that AMBN might exert its effects on osteoclastogenesis and mineral homeostasis through cell adhesion related mechanisms.
In support of this concept, AMBN treatment significantly enhanced adhesion of both Raw cells (data not shown) and BMMCs (Fig. 6A) , and this effect was dosage-dependent (Fig. 6A) . Both BSA and recombinant mouse amelogenin (rmAMEL, another enamel matrix protein) were used as controls and did not affect cell adhesion (Fig. 6A) .
Adhesion of cells to ECM initiates signaling pathways which lead cellular spreading and polarization. Potential intermediaries that might modulate the effect of AMBN on BMMCs include extracellular-signal-regulated kinases (ERK) and phosphatidylinositol 3-kinases (PI3K), both of which have been implicated in the regulation of cell adhesion and osteoclastogenesis and act as second messengers [28, 29] .
To determine whether AMBN affects ERK and PI3K pathways, ERK1/2 and AKT phosphorylation was examined by Western blot. Our study indicated that AMBN treatment enhanced ERK 1/2 and AKT phosphorylation 15 minutes after cell seeding.
The level of ERK1/2 phosphorylation was 1.6-fold and AKT phosphorylation was 2.3-fold higher in the AMBN treated group than in the BSA group (Fig. 6B, p<0 .05). Fold increase in ERK1/2 phosphorylation was calculated from the sum of the bands detectable on the western and from three independent experiments.
AMBN regulates osteoclast podosome and actin ring formation and is involved in 21
and MER pathways Adhesive interaction between cells and ECM proteins is mediated by cell surface receptor integrins. It has been reported that the rodent AMBN protein contains a potential α2β1 integrin binding domain and a thrombospondin cell adhesion motif [23] .
To determine whether integrins participate in AMBN-mediated cell adhesion and subsequent spreading, an anti-α2β1 integrin antibody (10µg/ml) was used to neutralize the integrin receptors. In addition, we used the ERK1/2 inhibitor U0126 and the PI3K 
AMBN upregulates osteoclast activation-related protein expression through α2β1 and MER pathways
RhoA activity is required to induce integrin clustering and focal complex formation [30, 31] . To assess whether AMBN-mediated adhesion of BMMCs stimulated
RhoA activity, RhoA expression levels in response to AMBN treatment were examined using Western blot analysis. After four hours of cell seeding, there was RhoA expression in AMBN-treated cells was 2.2-fold increased compared to BSA-treated cells (Fig. 8,   p<0 .05). Two inhibitors of adhesion molecules/pathways, α2β1 antibody and UO126, inhibited the effect of AMBN on RhoA expression, with RhoA returning to control levels when AMBN was used in combination with adhesion inhibitory agents (Fig. 8) . To determine whether AMBN affects RANKL-stimulated expression of osteoclastogenic regulatory genes, NFATc1 and c-FOS expression was determined using Western blots (Fig. 8) . AMBN five times increased NFATc1 protein expression and doubled c-FOS expression as revealed by densitometry (Fig. 8, p<0 .01). These results further support our hypothesis that AMBN regulates osteoclast differentiation. In addition, the anti-α2β1
integrin antibody and the ERK-inhibitor UO126 efficiently suppressed AMBN-induced NFATc1 expression (Fig. 8) .
DISCUSSION
In the present study we have used a number of model systems to examine the relationship between the ECM protein AMBN and osteoclast mediated resorption of mineralized tissues such as bone and cementum. AMBN function was tested using both an overexpressing transgenic mouse line and an in vitro system in which BMMCs were exposed to AMBN surface coatings. osteoblasts. In the present study, K14-driven overexpression of AMBN in mouse molars resulted in a robust 5-fold enhancement of AMBN levels compared to controls, confirming the effectiveness of our epithelium-driven AMBN overexpression approach in mouse periodontal tissues. For our in vitro studies, we exploited AMBN's putative role as an extracellular matrix protein, using surface coating of culture plates as a well established method [33] [34] [35] to examine the effect of AMBN on osteoclast attachment and differentiation. Together, these studies indicated that AMBN significantly altered osteoclast activity, both in vivo and in vitro.
In developing tooth roots, AMBN was expressed in HERS, ERM, and PDL, as demonstrated by in situ hybridization and immunoreactions. Our data on AMBN expression in HERS and ERM match previous findings [18, 19, 36, 37] . Evidence of AMBN expression in HERS and ERM contributes to an expanded understanding of a group of proteins previously called "enamel proteins", including amelogenin, enamelin, AMBN, and others. In addition to ameloblasts and HERS [42] , AMBN has now also been identified in pulp cells [37] [38] [39] , osteoblasts, CD34+ cells and osteoclasts [40, 41] .
AMBN's function in bone remodeling involves homing and recruitment of CD34+ cells and commitment to an osteoblast or osteoclast pathway [40, 41] . Thus, AMBN function may go beyond its role as cell adhesion modulator in ameloblast differentiation and enamel formation [14, 17, [42] [43] [44] , and also include a role in bone formation and periodontal regeneration [41, 42, 45, 46] .
Enforced Ambn expression in our mouse model resulted in bone loss and tooth root resorption, and these defects were accompanied by higher osteoclast activity, actin ring and podosome belt formation, and increased number of TRAP positive cells.
Enhanced osteoclast activity in our Ambn overexpressors occurred without inflammatory stimuli, indicating that AMBN affects osteoclast activation directly and without inflammatory mediators. The effect of AMBN as it relates to bone, root, and tooth resorption suggests that AMBN activates classic mechanisms of osteoclastogenesis through modulation of attachment and RANKL activation. In support of this concept, our data indicated that AMBN increased BMMC adhesion and multinucleated osteoclast number through integrins and RhoA. Moreover, AMBN also directly enhanced the effect of RANKL and CSF-1 on osteoclastogenesis, suggesting that AMBN has the ability to trigger key mechanisms of osteoclast induction.
Supportive of a potential involvement of integrins in the effect of AMBN on mineralized tissue homeostasis, our study revealed that the AMBN-induced increase in osteoclast count was significantly reduced when antibodies against integrin α2β1 or an inhibitor against ERK-1 were applied to the culture medium. It has been welldocumented that αvβ3 and α2β1 are the most prominent integrins expressed in BMMCs and osteoclasts [47] . These integrins mediate osteoclast adhesion to bone matrix proteins and regulate cytoskeleton reorganization [48] . Other integrins αvβ5 and α9β1 are found in osteoclast precursors and regulate osteoclast formation and function [49, 50] .
Antibodies against integrin α2β1 only resulted in a partial block of osteoclastogenesis in family [51, 52] . These signaling pathways also play distinct roles in osteoclast differentiation and function [53, 54] . Cross-talk between pathways and positive/negative feedback loops are therefore likely to be involved in AMBN-mediated osteoclast dynamics. 
